Eur Rev Med Pharmacol Sci 2021; 25 (10): 3644-3644
DOI: 10.26355/eurrev_202105_25927

Long noncoding RNA AK027294 acts as an oncogene in non-small cell lung cancer by up-regulating STAT3

B. Chen, C.-H. Ling

Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long noncoding RNA AK027294 acts as an oncogene in non-small cell lung cancer by up-regulating STAT3, by B. Chen, C.-H. Ling, published in Eur Rev Med Pharmacol Sci 2019; 23 (3): 1102-1107–DOI: 10.26355/eurrev_201902_17000–PMID: 30779078” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

Long noncoding RNA AK027294 acts as an oncogene in non-small cell lung cancer by up-regulating STAT3

 

Free PDF Download

To cite this article

B. Chen, C.-H. Ling
Long noncoding RNA AK027294 acts as an oncogene in non-small cell lung cancer by up-regulating STAT3

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 10
Pages: 3644-3644
DOI: 10.26355/eurrev_202105_25927

Keywords Related articles:

  1. Long noncoding RNA AK027294 acts as an oncogene in non-small cell lung cancer by up-regulating STAT3
  2. Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer
  3. Long noncoding RNA ZFAS1 acts as an oncogene by targeting miR-193a-3p in human non-small cell lung cancer
  4. Long noncoding RNA ZFAS1 acts as an oncogene by targeting miR-193a-3p in human non-small cell lung cancer
  5. Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer